DUNCAN, P. J.
Claimant suffered a compensable injury that resulted in the partial amputation of his left index finger. He subsequently filed a “new or omitted medical condition claim” pursuant to ORS 656.267, seeking acceptance of a consequential condition that he described as “complex regional pain syndrome.” Employer denied the claim, but the Workers’ Compensation Board (the board) determined that it was compensable. Employer now seeks review of the board’s determination. The question on judicial review is whether the board correctly determined that it could address the compensability of the ultimately diagnosed condition — “CRPS II” — in the context of its review of employer’s denial of “complex regional pain syndrome.” Employer contends that the board erred in addressing the compensability of CRPS II, because that diagnosis was not encompassed within or placed at issue by the claim. We review the board’s order for substantial evidence and errors of law, ORS 656.298(7); ORS 183.482(8)(a), (c), and conclude that the board did not err in considering the compensability of the condition; therefore, we affirm.
Claimant suffered a compensable injury at work when he severed a portion of the tip of his left index finger with a circular saw. Employer accepted a claim for a partial index finger amputation. Following surgery and physical and occupational therapy, claimant was released to work. The claim was closed with an award of permanent partial disability compensation.
Claimant continued to experience pain and other symptoms in his finger, including hypersensitivity to mechanical stimuli, stiffness, discoloration, and cold sensitivity. Claimant’s primary care physician referred him to Dr. Starr, a pain management specialist. Starr believed that claimant’s symptoms indicated a dysfunction of claimant’s local sympathetic system, which Starr diagnosed as “complex regional pain syndrome,” also described as “dystrophy, reflex sympathetic.” For insurance billing purposes, Starr identified claimant’s condition under the International Classification of Diseases (ICD) as “dystrophy, reflex sympathetic, upper limb.” Reports and notes of claimant’s physicians [493]*493and physical therapists variously described claimant’s condition as “complex” or “chronic” regional pain syndrome, “reflex sympathetic dystrophy,” “CRPS” or “RSD.” Starr’s therapies, which included nerve-blocking injections into claimant’s neck, were directed to that diagnosis and reduced claimant’s symptoms for short periods of time but did not eliminate them. After Starr left the pain management clinic, claimant continued treatment with Dr. Haber, who recommended that claimant consider a spinal cord stimulator trial.
Claimant’s attorney submitted a request for employer to expand its acceptance to include “complex regional pain syndrome as a consequence of his industrial injury and accepted finger amputation,” which the parties agree constituted a “new or omitted medical condition” claim under ORS 656.267.
At employer’s request, claimant submitted to an independent medical examination (IME) by Dr. Button, a hand surgeon. Button reviewed claimant’s medical history. Although Button concluded that claimant’s symptoms were related to his injury, he disagreed that the symptoms indicated a dysfunction of claimant’s sympathetic system. Button stated that he did not believe claimant had “CRPS.” Rather, he concluded that claimant had “isolated hypersensitivity from the fingertip amputation.” Button did not think that claimant required any further medical treatment and expressed the view that claimant was medically stationary.
Based on Button’s report, employer denied claimant’s request to accept “complex regional pain syndrome.”1 Claimant requested a hearing to challenge the denial.
While claimant’s hearing request was pending, employer arranged for an examination of claimant by Dr. Ochoa, a neurologist. Ochoa conducted a number of tests and reviewed claimant’s medical records. Ochoa was skeptical of the diagnoses by Starr and Haber. Ochoa agreed with Button that claimant’s symptoms did not reflect any [494]*494“sympathetic” system dysfunction. Rather, he opined, claimant suffered from “a neuropathic pain syndrome” caused by an organic peripheral nerve injury at the site of the amputation, a condition that he said should be coded as “CRPS II.” In short, like Button, Ochoa believed that claimant was experiencing symptoms of an injury to the nerve itself at the site of the amputation.
Haber ultimately deferred to Ochoa’s diagnosis and agreed that the treatment approach for CRPS II would be different from the therapy that he and Starr had prescribed. By the time of the hearing, all of the physicians were in agreement that the correct diagnosis for claimant’s symptoms was CRPS II.
At the hearing on claimant’s challenge to the denial of his new or omitted medical condition claim, employer’s counsel explained that there is a significant difference between CRPS/RSD (which Ochoa labeled as “CRPS I” and described as a diagnosis applied to nerve symptoms when there is no nerve injury) and the ultimately diagnosed CRPS II (which involves actual injury to the nerve), and that the two conditions have different medical codes and treatments. Although, by the time of hearing, the diagnosis of CRPS II was not disputed, employer maintained that, in the posture of the claim, the administrative law judge (ALJ) lacked authority to address the compensability of CRPS II, because that condition, which had not been diagnosed at the time claimant filed his new or omitted condition claim, was not encompassed within the claim and, thus, was not encompassed within employer’s denial.2 As a result, in employer’s [495]*495view, the compensability of CRPS II was not properly before the ALJ.
The ALJ agreed with employer, reasoning that claimant’s doctors had abandoned the original diagnosis of CRPS/RSD, on which the new or omitted condition claim for “complex regional pain syndrome” had been based; further, the ALJ concluded, she did not have authority to consider the compensability of CRPS II, because that condition had not been claimed or denied under ORS 656.262(6)(d) or (7)(a).
On claimant’s appeal, the board reversed the ALJ, reasoning that claimant’s claim was broad enough to [496]*496encompass the diagnosis of CRPS II. The board further concluded that claimant’s CRPS II exists, that it was caused in major part by the work injury, ORS 656.005(7)(a)(A) (setting forth the major contributing cause standard of proof for a consequential condition), and that it was, therefore, compensable. The board awarded claimant his attorney fees and costs under ORS 656.386(1) and (2) for prevailing over employer’s denial of the claim.
Free access — add to your briefcase to read the full text and ask questions with AI
DUNCAN, P. J.
Claimant suffered a compensable injury that resulted in the partial amputation of his left index finger. He subsequently filed a “new or omitted medical condition claim” pursuant to ORS 656.267, seeking acceptance of a consequential condition that he described as “complex regional pain syndrome.” Employer denied the claim, but the Workers’ Compensation Board (the board) determined that it was compensable. Employer now seeks review of the board’s determination. The question on judicial review is whether the board correctly determined that it could address the compensability of the ultimately diagnosed condition — “CRPS II” — in the context of its review of employer’s denial of “complex regional pain syndrome.” Employer contends that the board erred in addressing the compensability of CRPS II, because that diagnosis was not encompassed within or placed at issue by the claim. We review the board’s order for substantial evidence and errors of law, ORS 656.298(7); ORS 183.482(8)(a), (c), and conclude that the board did not err in considering the compensability of the condition; therefore, we affirm.
Claimant suffered a compensable injury at work when he severed a portion of the tip of his left index finger with a circular saw. Employer accepted a claim for a partial index finger amputation. Following surgery and physical and occupational therapy, claimant was released to work. The claim was closed with an award of permanent partial disability compensation.
Claimant continued to experience pain and other symptoms in his finger, including hypersensitivity to mechanical stimuli, stiffness, discoloration, and cold sensitivity. Claimant’s primary care physician referred him to Dr. Starr, a pain management specialist. Starr believed that claimant’s symptoms indicated a dysfunction of claimant’s local sympathetic system, which Starr diagnosed as “complex regional pain syndrome,” also described as “dystrophy, reflex sympathetic.” For insurance billing purposes, Starr identified claimant’s condition under the International Classification of Diseases (ICD) as “dystrophy, reflex sympathetic, upper limb.” Reports and notes of claimant’s physicians [493]*493and physical therapists variously described claimant’s condition as “complex” or “chronic” regional pain syndrome, “reflex sympathetic dystrophy,” “CRPS” or “RSD.” Starr’s therapies, which included nerve-blocking injections into claimant’s neck, were directed to that diagnosis and reduced claimant’s symptoms for short periods of time but did not eliminate them. After Starr left the pain management clinic, claimant continued treatment with Dr. Haber, who recommended that claimant consider a spinal cord stimulator trial.
Claimant’s attorney submitted a request for employer to expand its acceptance to include “complex regional pain syndrome as a consequence of his industrial injury and accepted finger amputation,” which the parties agree constituted a “new or omitted medical condition” claim under ORS 656.267.
At employer’s request, claimant submitted to an independent medical examination (IME) by Dr. Button, a hand surgeon. Button reviewed claimant’s medical history. Although Button concluded that claimant’s symptoms were related to his injury, he disagreed that the symptoms indicated a dysfunction of claimant’s sympathetic system. Button stated that he did not believe claimant had “CRPS.” Rather, he concluded that claimant had “isolated hypersensitivity from the fingertip amputation.” Button did not think that claimant required any further medical treatment and expressed the view that claimant was medically stationary.
Based on Button’s report, employer denied claimant’s request to accept “complex regional pain syndrome.”1 Claimant requested a hearing to challenge the denial.
While claimant’s hearing request was pending, employer arranged for an examination of claimant by Dr. Ochoa, a neurologist. Ochoa conducted a number of tests and reviewed claimant’s medical records. Ochoa was skeptical of the diagnoses by Starr and Haber. Ochoa agreed with Button that claimant’s symptoms did not reflect any [494]*494“sympathetic” system dysfunction. Rather, he opined, claimant suffered from “a neuropathic pain syndrome” caused by an organic peripheral nerve injury at the site of the amputation, a condition that he said should be coded as “CRPS II.” In short, like Button, Ochoa believed that claimant was experiencing symptoms of an injury to the nerve itself at the site of the amputation.
Haber ultimately deferred to Ochoa’s diagnosis and agreed that the treatment approach for CRPS II would be different from the therapy that he and Starr had prescribed. By the time of the hearing, all of the physicians were in agreement that the correct diagnosis for claimant’s symptoms was CRPS II.
At the hearing on claimant’s challenge to the denial of his new or omitted medical condition claim, employer’s counsel explained that there is a significant difference between CRPS/RSD (which Ochoa labeled as “CRPS I” and described as a diagnosis applied to nerve symptoms when there is no nerve injury) and the ultimately diagnosed CRPS II (which involves actual injury to the nerve), and that the two conditions have different medical codes and treatments. Although, by the time of hearing, the diagnosis of CRPS II was not disputed, employer maintained that, in the posture of the claim, the administrative law judge (ALJ) lacked authority to address the compensability of CRPS II, because that condition, which had not been diagnosed at the time claimant filed his new or omitted condition claim, was not encompassed within the claim and, thus, was not encompassed within employer’s denial.2 As a result, in employer’s [495]*495view, the compensability of CRPS II was not properly before the ALJ.
The ALJ agreed with employer, reasoning that claimant’s doctors had abandoned the original diagnosis of CRPS/RSD, on which the new or omitted condition claim for “complex regional pain syndrome” had been based; further, the ALJ concluded, she did not have authority to consider the compensability of CRPS II, because that condition had not been claimed or denied under ORS 656.262(6)(d) or (7)(a).
On claimant’s appeal, the board reversed the ALJ, reasoning that claimant’s claim was broad enough to [496]*496encompass the diagnosis of CRPS II. The board further concluded that claimant’s CRPS II exists, that it was caused in major part by the work injury, ORS 656.005(7)(a)(A) (setting forth the major contributing cause standard of proof for a consequential condition), and that it was, therefore, compensable. The board awarded claimant his attorney fees and costs under ORS 656.386(1) and (2) for prevailing over employer’s denial of the claim. But, reasoning that Button’s report had supported a legitimate doubt as to the compensa-bility of claimant’s condition, the board declined to assess a penalty under ORS 656.262(11)(a).3
On judicial review, employer reiterates the arguments it made before the board. Specifically, employer contends that the pertinent statutes require a claimant seeking acceptance of a new or omitted medical condition to specify the diagnosed condition for which compensation is sought, and the diagnosis controls an employer’s processing obligation. Therefore, in this case, because the diagnosis at the time claimant filed his claim ultimately proved to be incorrect, employer’s denial was proper. In addition, employer contends that because claimant had not specifically requested acceptance of CRPS II, employer had no obligation to process a claim for that condition; accordingly, employer asserts that its denial did not encompass CRPS II. Finally, citing SAIF v. Calder, 157 Or App 224, 227-28, 969 P3d 1050 (1998), for the proposition that the board is not an agency with specialized medical expertise, employer contends that, in concluding that claimant’s claim was broad enough to encompass CRPS II, the board made a medical determination that it was not qualified to make.4
Claimant responds that the board correctly concluded that his claim for “complex regional pain syndrome” placed at issue the compensability of the ultimate diagnosis of CRPS II, and that that determination was not a medical determination but rather a finding supported by medical [497]*497evidence in the record. Claimant asserts that the board’s determination that his claim is compensable is supported by substantial evidence. We agree with both of claimant’s contentions.5
Substantial evidence supports the board’s determination that claimant’s new or omitted medical condition claim placed at issue the compensability of the ultimately diagnosed CRPS II. The statutes governing new and omitted condition claims require that a claimant identify and give notice to the employer of the new or omitted condition for which compensation is sought. ORS 656.262(7)(a); ORS 656.267. We have frequently said that the scope of an employer’s acceptance or denial of a claim is a question of fact to be reviewed for substantial evidence. See, e.g., Walker v. Providence Health Systems Oregon, 267 Or App 87, 107, 340 P3d 91 (2014), modified on recons, 269 Or App 404, 344 P3d 1115 (2015); SAIF v. Dobbs, 172 Or App 446, 451, 19 P3d 932, adh’d to on recons, 173 Or App 599, 23 P3d 987 (2001) (scope of acceptance question of fact). We conclude here that whether a condition is encompassed within a new or omitted condition claim is also a question of fact that we review for substantial evidence. See Crawford v. SAIF, 241 Or App 470, 477-78, 250 P3d 965 (2011) (whether a claimant has stated a claim for an omitted condition is a question of fact). Here, the board found that claimant’s new or omitted medical condition claim for “complex regional pain syndrome” placed at issue the compensability of the ultimately-diagnosed condition of CRPS II. We agree with claimant that the board’s finding is supported by the medical evidence in the record and does not represent a medical determination by the board. There appears to be significant controversy in the medical community, between specialists [498]*498in pain management and specialists in neurology, concerning the etiology, nomenclature, and therapies for symptoms like claimant’s.6 The label “CRPS” has been applied to claimant’s symptoms from the beginning. Claimant’s new or omitted medical condition claim, as filed, was for “complex regional pain syndrome.” Although CRPS II was not diagnosed until after the claim was filed, a reasonable interpretation of the medical record is that CRPS II is a form of “complex regional pain syndrome.”7 Thus, the board did not err in concluding that the claim encompassed the ultimately-diagnosed condition.
Employer contends that it could not have known that claimant was seeking acceptance of CRPS II at the time of the claim, because that diagnosis had not been made.8 But ORS 656.262(7)(a) and ORS 656.267 require notice of new medical conditions', they do not require notice of diagnoses.9 A particular diagnosis is not required to support [499]*499the compensability of a work-related condition. See Boeing Aircraft Co. v. Roy, 112 Or App 10, 15, 827 P2d 915 (1992) (a claimant need not prove a specific diagnosis if he proves that his symptoms are attributable to work); Tripp v. Ridge Runner Timber Services, 89 Or App 355, 358, 749 P2d 586 (1988) (despite diagnostic difficulties, medical evidence attributing claimant’s condition to work was sufficient to support compensability). The record in this case shows that, although the medical experts disagreed about the correct diagnosis of claimant’s condition, the symptoms underlying the condition — hypersensitivity to mechanical stimuli, stiffness, discoloration, and cold sensitivity — remained constant and provided the basis for claimant’s new or omitted medical condition claim for “complex regional pain syndrome.” On this record, the board could find that the source of claimant’s symptoms, ultimately diagnosed as CRPS II, is the same condition for which claimant originally sought acceptance as “complex regional pain syndrome.” We conclude that the board’s finding that the claim encompassed the ultimately diagnosed condition of CRPS II is supported by substantial evidence.
Affirmed.